Metagenomi (MGX) Accumulated Depreciation & Amortization (2023 - 2025)
Metagenomi (MGX) has disclosed Accumulated Depreciation & Amortization for 3 consecutive years, with $16.0 million as the latest value for Q4 2025.
- On a quarterly basis, Accumulated Depreciation & Amortization rose 41.64% to $16.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $16.0 million, a 41.64% increase, with the full-year FY2025 number at $16.0 million, up 41.64% from a year prior.
- Accumulated Depreciation & Amortization was $16.0 million for Q4 2025 at Metagenomi, up from $11.3 million in the prior quarter.
- In the past five years, Accumulated Depreciation & Amortization ranged from a high of $16.0 million in Q4 2025 to a low of $6.4 million in Q4 2023.
- A 3-year average of $11.2 million and a median of $11.3 million in 2024 define the central range for Accumulated Depreciation & Amortization.
- Peak YoY movement for Accumulated Depreciation & Amortization: soared 75.15% in 2024, then surged 41.64% in 2025.
- Metagenomi's Accumulated Depreciation & Amortization stood at $6.4 million in 2023, then skyrocketed by 75.15% to $11.3 million in 2024, then soared by 41.64% to $16.0 million in 2025.
- Per Business Quant, the three most recent readings for MGX's Accumulated Depreciation & Amortization are $16.0 million (Q4 2025), $11.3 million (Q4 2024), and $6.4 million (Q4 2023).